Formoterol Turbuhaler® reduces the need for relief medication in children with mild to moderate asthma and improves quality of life Source: Eur Respir J 2001; 18: Suppl. 33, 291s Year: 2001
Effects of adding salmeterol to inhaled corticosteroids on lung function and quality of life in patients with mild persistent asthma Source: Eur Respir J 2006; 28: Suppl. 50, 499s Year: 2006
Maintenance therapy with budesonide and formoterol in chronicobstructive pulmonary disease Source: Eur Respir J 2003 Dec 01;22(6):912-919 Year: 2003
Dual bronchodilation with once-daily QVA149 improves dyspnea and health status and reduces symptoms and rescue medication use in patients with COPD: The IGNITE trials Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs Year: 2013
The effect of smoking on severity of asthma and quality of life in patients treated with inhaled corticosteroids and long-acting b2-agonist (ICS/LABA) Source: Annual Congress 2012 - Translational respiratory medicine in asthma and COPD Year: 2012
Adding omalizumab to high-dose ICS and LABA significantly improves quality of life in patients with severe persistent allergic asthma Source: Eur Respir J 2006; 28: Suppl. 50, 440s Year: 2006
Salmeterol/fluticasone (seretide, S/F) used as needed improves health-related quality of life in asthmatic adolescents uncontrolled with ICS receiving inhaled short-acting β2 agonists (SAB2A) Source: Eur Respir J 2004; 24: Suppl. 48, 380s Year: 2004
Budesonide/formoterol for maintenance and relief in adolescents with asthma: fewer exacerbations and improved asthma control Source: Eur Respir J 2004; 24: Suppl. 48, 164s Year: 2004
Reduction in oral corticosteroid use with mometasone furoate DPI improves health-related quality of life in patients with severe persistent asthma Source: Eur Respir J 2002; 20: Suppl. 38, 395s Year: 2002
Efficacy, safety and acceptance of salbutamol administered via MAGhaler in children with mild to moderate asthma Source: Eur Respir J 2002; 20: Suppl. 38, 430s Year: 2002
Patients with moderate asthma symptoms may benefit from short-term inhaled corticosteroid monotherapy Source: Eur Respir J 2007; 30: Suppl. 51, 615s Year: 2007
Tiotropium add-on therapy reduces seasonal peaks of asthma worsening in adults with symptomatic severe asthma Source: Eur Respir J, 55 (1) 1900964; 10.1183/13993003.00964-2019 Year: 2020
Add-on effects of long-acting beta2 -agonists salmeterol inhaler vs tulobuterol patch in adult patients with mild-to-moderate asthma Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs Year: 2013
Pretreatment with inhaled procaterol improves symptoms of dyspnea and quality of life in patients with severe COPD Source: Annual Congress 2012 - COPD treatments: efficacy and safety Year: 2012
Combined therapy in school children with severe asthma and their quality of life Source: Eur Respir J 2005; 26: Suppl. 49, 396s Year: 2005
Efficacy of long-term formoterol therapy vs as-needed salbutamol use in patients with moderate asthma Source: Eur Respir J 2001; 18: Suppl. 33, 426s Year: 2001
Tiotropium reduces oral prednisone requirements while improving respiratory function in patients with severe persistent asthma Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma Year: 2016
Quality of life of patients with asthma exacerbations treated with high doses of inhaled corticosteroids Source: Eur Respir J 2002; 20: Suppl. 38, 114s Year: 2002
Potential masking effect on dyspnoea perception by short- and long-acting β2-agonists in asthma Source: Eur Respir J 2002; 19: 240-245 Year: 2002
Children with mild asthma: do they benefit from inhaled corticosteroids? Source: Eur Respir J 2002; 20: 1470-1475 Year: 2002